BR0014656A - Agentes terapêuticos - Google Patents
Agentes terapêuticosInfo
- Publication number
- BR0014656A BR0014656A BR0014656-0A BR0014656A BR0014656A BR 0014656 A BR0014656 A BR 0014656A BR 0014656 A BR0014656 A BR 0014656A BR 0014656 A BR0014656 A BR 0014656A
- Authority
- BR
- Brazil
- Prior art keywords
- therapeutic agents
- pyridin
- ylsulphonyl
- ethylpiperazin
- pyrazolo
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Dermatology (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Vascular Medicine (AREA)
- Gynecology & Obstetrics (AREA)
- Otolaryngology (AREA)
- Psychiatry (AREA)
- Ophthalmology & Optometry (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Separation Of Suspended Particles By Flocculating Agents (AREA)
Abstract
"AGENTES TERAPêUTICOS". A invenção refere-se aos sais anidros de ácido para-toluenossulfónico de 3-etil-5-[5-(4-etilpiperazin-1-ilsulfonil)-2-(2-metoxietóxi)piridin-3-il]-2-(piri din-2-il)metil-2,6-di-hidro-7H-pirazolo[4,3-d]pirimidin-7-ona tendo a fórmula (I): um processo para a preparação dos compostos (I), composições farmacêuticas contendo (I) e a utilização de (I) em medicina.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9923968.3A GB9923968D0 (en) | 1999-10-11 | 1999-10-11 | Therapeutic agents |
PCT/IB2000/001445 WO2001027101A2 (en) | 1999-10-11 | 2000-10-06 | Anhydrous salt |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0014656A true BR0014656A (pt) | 2002-06-11 |
Family
ID=10862471
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0014656-0A BR0014656A (pt) | 1999-10-11 | 2000-10-06 | Agentes terapêuticos |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP1220855B1 (pt) |
JP (1) | JP2003511446A (pt) |
AT (1) | ATE267203T1 (pt) |
AU (1) | AU7441100A (pt) |
BR (1) | BR0014656A (pt) |
CA (1) | CA2382937A1 (pt) |
CO (1) | CO5271692A1 (pt) |
DE (1) | DE60010914T2 (pt) |
DK (1) | DK1220855T3 (pt) |
ES (1) | ES2219395T3 (pt) |
GB (1) | GB9923968D0 (pt) |
PA (1) | PA8503701A1 (pt) |
PE (1) | PE20010674A1 (pt) |
PT (1) | PT1220855E (pt) |
SV (1) | SV2002000191A (pt) |
TN (1) | TNSN00196A1 (pt) |
WO (1) | WO2001027101A2 (pt) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL158738A0 (en) * | 2001-05-09 | 2004-05-12 | Bayer Healthcare Ag | Novel use of 2-phenyl-substituted imidazotriazinones |
GB0126417D0 (en) * | 2001-11-02 | 2002-01-02 | Pfizer Ltd | Crystal structure |
DE10232113A1 (de) | 2002-07-16 | 2004-01-29 | Bayer Ag | Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel |
JP2006525801A (ja) * | 2003-05-01 | 2006-11-16 | ファイザー・インク | Pde5の結晶、その結晶構造及び創薬におけるその使用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ338075A (en) * | 1997-04-25 | 2000-10-27 | Pfizer Ltd | Pyrazolopyrimidinones which inhibit type 5 cyclic guanosine 3',5'-monophosphate phosphodiesterase (cGMP PED5) for the treatment of sexual dysfunction |
TR200003039T2 (tr) * | 1998-04-20 | 2001-01-22 | Pfizer Inc. | Seksüel fonksiyon bozukluklarının tedavisi için pirazolopirimidinon cGMP PDE5 inhibitörleri |
-
1999
- 1999-10-11 GB GBGB9923968.3A patent/GB9923968D0/en not_active Ceased
-
2000
- 2000-09-27 PA PA20008503701A patent/PA8503701A1/es unknown
- 2000-10-05 PE PE2000001054A patent/PE20010674A1/es not_active Application Discontinuation
- 2000-10-06 WO PCT/IB2000/001445 patent/WO2001027101A2/en active IP Right Grant
- 2000-10-06 AU AU74411/00A patent/AU7441100A/en not_active Abandoned
- 2000-10-06 CA CA002382937A patent/CA2382937A1/en not_active Abandoned
- 2000-10-06 DK DK00962772T patent/DK1220855T3/da active
- 2000-10-06 JP JP2001530319A patent/JP2003511446A/ja active Pending
- 2000-10-06 DE DE60010914T patent/DE60010914T2/de not_active Expired - Fee Related
- 2000-10-06 PT PT00962772T patent/PT1220855E/pt unknown
- 2000-10-06 EP EP00962772A patent/EP1220855B1/en not_active Expired - Lifetime
- 2000-10-06 BR BR0014656-0A patent/BR0014656A/pt not_active IP Right Cessation
- 2000-10-06 ES ES00962772T patent/ES2219395T3/es not_active Expired - Lifetime
- 2000-10-06 AT AT00962772T patent/ATE267203T1/de not_active IP Right Cessation
- 2000-10-10 TN TNTNSN00196A patent/TNSN00196A1/fr unknown
- 2000-10-10 SV SV2000000191A patent/SV2002000191A/es unknown
- 2000-10-10 CO CO00077030A patent/CO5271692A1/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
PT1220855E (pt) | 2004-08-31 |
JP2003511446A (ja) | 2003-03-25 |
CO5271692A1 (es) | 2003-04-30 |
TNSN00196A1 (fr) | 2005-11-10 |
ES2219395T3 (es) | 2004-12-01 |
PA8503701A1 (es) | 2001-10-10 |
WO2001027101A3 (en) | 2001-06-14 |
SV2002000191A (es) | 2002-01-23 |
DK1220855T3 (da) | 2004-09-27 |
AU7441100A (en) | 2001-04-23 |
DE60010914T2 (de) | 2004-10-28 |
EP1220855A2 (en) | 2002-07-10 |
PE20010674A1 (es) | 2001-06-27 |
GB9923968D0 (en) | 1999-12-15 |
CA2382937A1 (en) | 2001-04-19 |
ATE267203T1 (de) | 2004-06-15 |
EP1220855B1 (en) | 2004-05-19 |
DE60010914D1 (de) | 2004-06-24 |
WO2001027101A2 (en) | 2001-04-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
YU6303A (sh) | Nova heterociklična jedinjenja, njihovo dobijanje i njihova upotreba kao medikamenata, a naročito kao anti-bakterijskih agenasa | |
DK0911333T3 (da) | Pyrazol [4,3-d]pyrimidinderivater og farmaceutiske præparater, der indeholder disse | |
MXPA03011039A (es) | Nuevos compuestos heterociclicos, su preparacion y uso como medicamentos, particularmente como agentes anti-bacterianos. | |
WO1999064409A3 (de) | Benzothiepin-1,1-dioxidderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung | |
SE9904505D0 (sv) | Novel compounds | |
IL185611A0 (en) | Novel imidazo[1,5-a]pyridine derivatives, method for preparing same and pharmaceutical compositions containing same | |
ATE316083T1 (de) | Adamantanderivate | |
ATE325611T1 (de) | Borsäuresalze und deren verwendung in der bereitstellung von medikamente für die thrombosebehandlung | |
BR9812492A (pt) | Composto, uso do mesmo, formulação farmacêutica, e, processos para o tratamento de uma doença cardiovascular, para o tratamento de uma vasoconstrição, e para a preparação de compostos | |
ATE300541T1 (de) | Pyrazolopyridinderivate | |
GB0109122D0 (en) | Novel compounds | |
MY114944A (en) | Propanolamine derivatives, processes for their preparation pharmaceuticals comprising these compounds, and their use | |
SG145570A1 (en) | 4-æ7-halo-2-quino(xa-)linyloxy!phenoxy-propionic acid derivatives as antineoplastic agents | |
CA2298461A1 (en) | Heterocyclic substituted 4-benzoyl-pyrazole as herbicides | |
MXPA04005484A (es) | Procedimiento de preparacion de derivados de equinocandina. | |
PA8503701A1 (es) | Agentes terapeuticos | |
SE0102057D0 (sv) | New Salts I | |
AU530678B2 (en) | Phosphono-hydroxy-acetic acid | |
TR199801191T2 (xx) | �o�ul ila� direnci mod�lat�rleri olarak kayna��k imidazol t�revleri. | |
MY113529A (en) | New derivatives of imidazole n- benzyldioxole,processes for their preparation, their use as medicaments and pharmaceutical compositions containing them | |
SE0102058D0 (sv) | New Salts II | |
AU2001244999A1 (en) | Naphthamide neurokinin antagonists for use as medicaments | |
SE9803280D0 (sv) | Novel compounds | |
UY26382A1 (es) | Agentes terapéuticos | |
SE9803277D0 (sv) | Novel compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A,7A E 8A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1962 DE 12/08/2008. |